Clarnette, Roger
The University of Western Australia · Australian Alzheimer’s Research Foundation
3 papers on CoChat
Most cited papers
- Verified
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
Salloway, S., Farlow, M., McDade, E., Clifford, D. B., Wang, G., Llibre-Guerra, J. J., Hitchcock, J. M., Mills, S. L., Santacruz, A. M., Aschenbrenner, A. J., et al. (2021) · Nature Medicine
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 359
- Verified
Cognitive impairment, physical disability and depressive symptoms in older diabetic patients: the Fremantle Cognition in Diabetes Study
Bruce, D. G., Casey, G. P., Grange, V., Clarnette, R. C., Almeida, O. P., Foster, J. K., Ives, F. J., & Davis, T. M. E. (2003) · Diabetes Research and Clinical Practice
Dementia and Cognitive Impairment ResearchAging, Health, and Disability
Cited by 145
- Verified
Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer’s disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial.
Burns, D. K., Alexander, R. C., Welsh-Bohmer, K. A., Culp, M., Chiang, C., O’Neil, J., Evans, R. M., Harrigan, P., Plassman, B. L., Burke, J. R., et al. (2021) · The Lancet Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 130
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free